Table 1 Characteristics of subjects.
Characteristic | CA + DRY (n = 8) | OX + DRY (n = 8) | CA + HUMID (n = 7) | OX + HUMID (n = 8) | P value |
|---|---|---|---|---|---|
Age (year), mean ± SD | 28.8 ± 6.7 | 27.0 ± 2.9 | 25.0 ± 1.6 | 25.8 ± 2.1 | N.S. |
Male, n (%) | 2 (25%) | 1 (12.5%) | 0 (0%) | 2 (25%) | N.S. |
Female, n (%) | 6 (75%) | 7 (87.5%) | 7 (100%) | 6 (75%) | N.S. |
BMI (kg/m2) | 22.5 ± 2.2 | 23.3 ± 2,7 | 24.8 ± 7.3 | 27.1 ± 8.2 | N.S. |
Pulse rate (bpm) | 74.7 ± 11.0 | 80.0 ± 10.1 | 75.7 ± 9.2 | 82.0 ± 13.9 | N.S. |
Body temperature (°C) | 36.0 ± 0.4 | 35.9 ± 0.4 | 36.4 ± 0.2 | 35.9 ± 0.5 | N.S. |
Peripheral oxygen saturation (%), mean ± SD | 98.7 ± 0.4 | 97.7 ± 1.0 | 98.5 ± 0.5 | 98.3 ± 0.5 | N.S. |
Blood pressure | |||||
Systolic (mmHg), mean ± SD | 108.7 ± 13.5 | 100.0 ± 0.0 | 111.5 ± 3.5 | 103.5 ± 11.8 | N.S. |
Diastolic (mmHg), mean ± SD | 70.0 ± 8.6 | 67.5 ± 8.8 | 80.0 ± 0.0 | 75.0 ± 7.5 | N.S. |
Medications, n (%) | |||||
Contraceptive | 2 (25%) | 3 (37.5%) | 1 (12.5%) | 0 (0%) | N.S. |
Pantoprazole | 1 (12.5%) | 0 (0%) | 0 (0%) | 0 (0%) | N.S. |
Sodium levothyroxine | 1 (12.5%) | 0 (0%) | 1 (12.5%) | 0 (0%) | N.S. |
Clomipramine | 1 (12.5%) | 0 (0%) | 0 (0%) | 0 (0%) | N.S. |
Finasterida | 0 (0%) | 1 (12.5%) | 0 (0%) | 1 (12.5%) | N.S. |
Alprazolam | 0 (0%) | 1 (12.5%) | 0 (0%) | 0 (0%) | N.S. |
Amitriptyline | 0 (0%) | 0 (0%) | 1 (12.5%) | 0 (0%) | N.S. |
Trazodone | 0 (0%) | 0 (0%) | 0 (0%) | 1 (12.5%) | N.S. |
